Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
80.94 USD | +1.75% | +4.62% | +4.80% |
05-06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
05-02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.80% | 12.55B | |
+18.15% | 47.02B | |
+48.77% | 41.86B | |
+0.99% | 41.76B | |
-4.27% | 28.8B | |
+11.30% | 26.05B | |
-21.29% | 19.15B | |
+27.47% | 12.34B | |
-3.78% | 11.82B | |
+20.18% | 11.8B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Transcript : Bio-Techne Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08